Restriction point regulation at the crossroads between quiescence and cell proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Restriction point regulation at the crossroads between quiescence and cell proliferation

Published:2020-07 Issue:13 Volume:594 Page:2046-2060
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Pennycook Betheney R.¹²^ORCID,Barr Alexis R.¹²^ORCID

Affiliation:

1. Institute of Clinical Sciences Faculty of Medicine Imperial College London London UK

2. MRC London Institute of Medical Sciences Imperial College London London UK

Funder

Medical Research Council

Cancer Research UK

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.13867

Reference151 articles.

1. Cell cycle, CDKs and cancer: a changing paradigm

2. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology

3. Preparation for DNA replication: the key to a successful S phase

4. A New Description of Cellular Quiescence

5. A Restriction Point for Control of Normal Animal Cell Proliferation

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxic reactivation of Kaposi’s Sarcoma associated Herpesvirus;Cell Insight;2024-09

2. From dusk till dawn: cell cycle progression in the red seaweed Gracilariopsis chorda (Rhodophyta);iScience;2024-07

3. Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs);Cell Death Discovery;2024-06-11

4. The Nucleolar Protein C1orf131 Is a Novel Gene Involved in the Progression of Lung Adenocarcinoma Cells through the AKT Signalling Pathway;International Journal of Molecular Sciences;2024-06-09

5. Pro-survival roles for p21(Cip1/Waf1) in Non-Small Cell Lung Cancer;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3